Zimbabwe has declined a major US health deal valued at 367 million US dollars (£272m) spanning five years because of Washington's insistence on sensitive biological samples.
This rejection was revealed following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the deal was "lopsided".
A government spokesperson later clarified that the US was seeking genetic material for research and commercial gain while was unwilling to share the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for further talks to secure a agreement acceptable to both sides so the nation's vital HIV treatment initiative can proceed.
Broader Context
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were raised about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump argued its spending was "inefficient" and his government was seeking government-to-government agreements to boost transparency and accountability.
Based on reports, 16 nations in Africa have to date signed these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"In essence, our country would provide the raw materials for scientific discovery without any assurance that the end products would be accessible to our citizens if a future pandemic arise."
National Interest and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral deals were disrupting structures previously set up through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.
"This framework is designed to guarantee that when a country provides its data, the resulting advantages – including medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We welcome ongoing discussions with our US partners on how future collaboration could be designed in a manner that respects the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that talks must proceed since a large portion of the country's HIV programmes were funded by international support.
"Where technical issues exist, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," it said.
The situation highlights the continuing challenges between receiving much-needed foreign assistance and safeguarding a country's data in an ever more interconnected world.